Avatrombopag, marketed as Doptelet, is an orally administered medication primarily used to treat thrombocytopenia (low platelet count) in adults with chronic liver disease who are scheduled for a medical or dental procedure, and in patients with chronic immune thrombocytopenia (ITP) who have not res ...
Avatrombopag, marketed as Doptelet, is an orally administered medication primarily used to treat thrombocytopenia (low platelet count) in adults with chronic liver disease who are scheduled for a medi ...